Related Experiment Video
Updated: Aug 11, 2026

10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
The problem of classifying lymphomas: an orderly prescription for progress
1St. Jude Children's Research Hospital, Memphis, TN, USA.
Summary
The evolution of non-Hodgkin
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Early non-Hodgkin's lymphoma classifications relied solely on morphology.
- Immunologic and histochemical markers revolutionized lymphoma understanding, highlighting their immune system origin.
- Conflicting classifications in the 1970s necessitated a standardized approach.
Purpose of the Study:
- To address the confusion caused by numerous lymphoma classifications.
- To establish a consensus for diagnosing and classifying non-Hodgkin's lymphomas.
- To facilitate translation between different classification systems.
Main Methods:
- A large-scale retrospective study was conducted from 1976 to 1980.
- Expert pathologists and clinicians collaborated through international workshops.
- The study aimed to provide data for meaningful progress in lymphoma classification.
Main Results:
- The collaborative study formed the basis for the Working Formulation for Clinical Usage (published 1982).
- Subsequent advances in immunology, cytogenetics, and molecular biology led to new proposals.
- The 'A Revised European-American Classification of Lymphoid Neoplasms' (1994) emerged from further international collaboration.
Conclusions:
- The Working Formulation served as a crucial translation tool among existing lymphoma classification schemas.
- Ongoing international efforts, including those by the World Health Organization, continue to refine lymphoma classification.
- These historical and ongoing efforts exemplify progress in clinicopathologic understanding of cancers.
More Related Videos
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
Related Concept Videos
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...